Mindray to Attend 2008 CLSA Asia Investors' Forum

Saturday, December 29, 2007 General News J E 4
SHENZHEN, China, Dec. 28 Mindray MedicalInternational Limited (NYSE: MR), a leading developer, manufacturer andmarketer of medical devices in China with a rapidly growing internationalpresence, today announced Mr. Xu Hang, Mindray's chairman and co-chiefexecutive officer, Ms. Joyce Hsu, chief financial officer, and Mr. ChengMinghe, executive vice president of strategic development, will attend the2008 CLSA Asia Investors' Forum held at the Four Seasons Hotel in Las Vegas,Nevada from Monday, January 14, 2008 to Thursday, January 17, 2008. Mr. Xuwill present on Monday, January 14, 2008 at 10:00 am Pacific Standard Time.

Mr. Xu will discuss Mindray's recent developments and 2008 domestic andinternational strategy. This presentation will be webcast and will beavailable on the company's website at .

About Mindray

Mindray Medical International Limited is a leading developer, manufacturerand marketer of medical devices in China with a significant and growingpresence worldwide. Established in 1991, Mindray offers a broad range ofproducts across three primary business segments: patient monitoring devices,diagnostic laboratory instruments, and ultrasound imaging systems. Mindray isheadquartered in Shenzhen, China, and has 29 local sales and service officesin China, as well as sales and service offices in Amsterdam, Boston, Istanbul,London, Mexico City, Mumbai, Sao Paulo, Seattle, Toronto and Vancouver. Formore information, please visit .For investor and media inquiries please contact: In China: Investor Relations Mindray Medical International Limited Tel: +86-755-2658-2518 Email: Justin Knapp Ogilvy Public Relations Worldwide, Beijing Tel: +86-10-8520-6556 Email: In the United States: Jeremy Bridgman Ogilvy Public Relations Worldwide, New York Tel: +1-212-880-5363

SOURCE Mindray Medical International Limited


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
FASgen Announces New Research Discoveries in Lung ...
Mylan Announces Final FDA Approval for Cetirizine ...